Azitra Share Price

Azitra Share Price

AMEX: AZTR | Healthcare
$0.00
-$0.60 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Azitra Stock Performance

Open
N/A
Prev. Close
$0.60
Circuit Range
N/A
Day Range
N/A
Year Range
$0.07 - $1.31
Volume
N/A
Average Traded
N/A

Azitra Share Price Chart

Line chart of the Azitra price trend over the selected period. The price fell overall, ranging from 0.60 to 0.60, ending at 0.60.
$0.00$0.00
L
Show Current Price
H

Azitra Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-283.30%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-32.29%

Azitra Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.23-$3.93-$3.35-$2.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-76.23%14.76%11.94%

Azitra Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.69$0.01$0.00
Net Profit-$12.64-$8.97-$10.96
Net Profit Margin-1831.88%-89700.00%N/A
Income ChangeN/A29.03%-22.19%

Azitra Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets2.012.132.58
Current Assets3.025.232.54
Total Assets5.037.365.12
Non Current Liabilities0.160.280.6
Current Liabilities1.071.381.6
Total Liabilities1.221.662.2
Shareholders' Equity3.85.72.91

Azitra Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-11.22-10.18-7.36
Investing-0.18-0.38-0.32
Financing8.9213.325.98

Corporate Actions

Split
Ex-date: 26 Oct 2026

Split
Ex-date: 21 Aug 2025

Split
Ex-date: 01 Jul 2024

About Azitra

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Azitra Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.75
$0.60
-23.59%
Oct 2026
$0.14
$0.78
+482.09%
Sep 2026
$0.17
$0.13
-28.72%
Aug 2026
$0.13
$0.19
+42.42%
Jul 2026
$0.16
$0.13
-19.51%
Jun 2026
$0.23
$0.16
-28.07%
May 2026
$0.25
$0.23
-11.28%
Apr 2026
$0.23
$0.26
+9.36%
Mar 2026
$0.17
$0.23
+33.52%
Feb 2026
$0.25
$0.18
-28.46%
Jan 2026
$0.28
$0.25
-8.55%
Dec 2025
$0.36
$0.27
-27.88%

Azitra Share Price FAQs